Recombinant Human CART Protein，His

CART (Cocaine and amphetamine-regulated transcript) is a neuropeptide that plays a critical role in the regulation of appetite, reward, and stress response. Initial studies on CART emerged from investigations into the neurobiological effects of drugs of abuse, such as cocaine and amphetamines, which were found to significantly alter CART expression in the brain. As research progressed, it became clear that CART is not only involved in substance use but also has broader implications for neuroendocrine function and metabolic regulation. The peptide is expressed in various regions of the brain, including the hypothalamus, which is crucial for governing feeding behavior and energy homeostasis. Furthermore, CART has been implicated in mood disorders, suggesting its potential as a target for therapeutic interventions in psychiatric conditions. Recent advances in recombinant protein technology have enabled the production of CART peptides for comprehensive studies on their biological activity and mechanisms of action. Researchers are investigating the signaling pathways modulated by CART and its interactions with other neuropeptides and neurotransmitters, aiming to elucidate its role in both physiological and pathological states. Overall, the study of CART recombinant proteins is essential for understanding their multifaceted roles in the brain, contributing to our knowledge of metabolic diseases, addiction, and mood regulation, and potentially guiding the development of innovative treatment strategies.